Fri, December 20th 2024
2024: End of the Year Review
As 2024 comes to an end, we reflect on a year marked by innovation in diagnostics and sample preparation and positive engagement with the world’s dynamic infectious disease community.
London UK, December 20th, 2024 - This year we've enjoyed many examples of innovation and great interaction with the infectious disease community. Here are some of the highlights:
Leadership Transition: Bob Enck Appointed as CEO
In a strategic move to drive commercial growth, Bob Enck, our Chairman and President, stepped into the role of CEO. With his leadership, ProtonDx is poised for robust expansion in 2025 and beyond.
Professor Pantelis Georgiou, Co-founder and Director of ProtonDx, said on Bob's apppointment:
“Bob's wealth of business experience and leadership acumen position him as a driving force behind the company's continued innovation, strategic relationships, and customer focused solutions."
SmartLid Kits: Transforming Blood Extraction
This year saw the launch of the SmartLid Blood Extraction Kit, which simplifies nucleic acid extraction from whole blood samples. Featuring our proprietary TurboBeads technology, this kit ensures unparalleled speed and precision, reducing sample preparation time to as little as 20 minutes.
Discover more about the SmartLid Blood Kit.
TurboBeads Acquisition: Enhancing Core Capabilities
ProtonDx took a significant step forward with the acquisition of TurboBeads, a leader in high-performance magnetic bead technology. TurboBeads now power our SmartLid kits, reinforcing our commitment to innovation in nucleic acid extraction.
Point-of-Care Diagnostics: Malaria and Mpox in LMICs
ProtonDx advanced its mission to make diagnostics accessible in low- and middle-income countries (LMICs) with projects in The Gambia, Burkina Faso, and elsewhere. Our platforms tackle urgent public health challenges in malaria and Mpox with innovations tailored for resource-limited settings.
Dragonfly Diagnostics in Extreme Conditions
ProtonDx’s Dragonfly platform proved its resilience in one of the harshest environments on Earth. Infectious disease specialist Major Scott Pallett tested Dragonfly 600 km north of the Arctic Circle, where it reliably diagnosed Influenza A cases in temperatures as low as -35°C.
Read more about this incredible journey.
Dr Daniel Grace's Livingstone Revisited expedition is promoting healthcare accessibility in Zambia, and Dragonfly's portable diagnostic platform is part of the expedition team - a further example of how this rapid and portable multi-pathogen diagnostic platform can work in challenging environments.
Celebrating Academic Achievements and Engaging the Global Community
ProtonDx co-founders and researchers attended the IEEE Biosensors 2024 Conference, showcasing groundbreaking work in biosensor technology. Highlights included PhD students Calista Adele Yapeter and Costanza Gulli winning the IEEE Women in Sensors Award and Prateek Tripathi securing the Best Paper award for innovations in neuromorphic electronics.
At Lab Innovations, ProtonDx Molecular Biologist Katerina Mantikis shared advances in rapid and portable molecular diagnostics using SmartLid and TurboBeads.
We attended events across the globe, including:
-
ECCMID
-
American Association Of Swine Veterinarians (AASV) Annual Meeting
-
VMX: Veterinary Meeting & Expo
-
50th Allen D Leman Swine Conference
-
Biomedical Advanced Research and Development Authority (BARDA) Innovation Symposium
-
Biotech Forum
-
MEDICA
-
London Infections & Immunity Symposium
-
St George's Research Day, University of London
-
Nipah Virus Research Day, University of Oxford
-
Biosciences Seminar, Brunel University of London
-
Bioengineering Careers Fair, Imperial College London
-
Lab Innovations Conference, Birmingham, UK
Expanding Partnerships: Joining MTEC
This year we became a Medical Technology Enterprise Consortium (MTEC) member to join the mission to advance medical solutions for military personnel and civilians.
Forging Animal Health Partnerships
This autumn we secured an exciting multi-year development project with industry and academic partners. We're looking forward to announcing more in the new year!
Looking Ahead to 2025
As we gear up for 2025, ProtonDx remains steadfast in its mission to transform diagnostics across diverse applications. From product expansion to strategic collaborations, we’re committed to delivering solutions that empower healthcare professionals and improve global health.
Stay connected for more updates at ProtonDx.com.
